2020 AACBS Annual General Meeting and Scientific Meeting will be hosted online in September 2020. Stay tuned!                        


Prof. Yong Li


Professor Yong Li                         

Tel: (02) 9113 1338;

Fax: (02) 9113 1386;




Dr Li is the Professor (Conjoint) in the Faculty of Medicine, UNSW Sydney; a Principal Scientific Officer at St George Hospital, the South Eastern Sydney Local Health District (SESLHD); and Head of Cancer Research Laboratory at Cancer Care Centre. He is an established cancer researcher, with expertise in cancer biomarker discovery, cancer biology, radiation biology, targeted cancer therapy and cancer metastasis. He was awarded an NHMRC Achievement Award in 2011. 


Professor Li obtained his Bachelor of Medicine (B.M) degree in 1987 and Master of Science (MSc) degree in 1992 from the Henan Medical University, China. He obtained his PhD. degree in Faculty of Medicine, University of New South Wales (UNSW), Sydney, Australia, in 2000. After two years of Postdoctoral study at UNSW, he was awarded the US Department Defence Prostate Cancer Research New Investigate Award in 2003 and then became an independent investigator. 


Professor Li has a career total of 120 publications in peer-reviewed journals (3450 Scopus citations, 5540 google citations) since 1999, including Blood, Journal of Biological Chemistry, Clinical Cancer Research, Theranostics and Advanced Materials. His Scopus h-index is 36 and Google i10 index is 80. 


Professor Li has attracted 7.2 million AU$ from different funding sources including NHMRC, ARC, US Department Defence, Cancer Institute NSW, and Prostate Cancer Foundation of Australia and Prostate and Breast Cancer Foundation (PBCF) as the principal investigator. He has supervised 14 PhD students as the principal supervisor or co-supervisor. 


Prof Li’s current research program is aimed at a): To investigate novel biomarkers from human body fluids for cancer diagnosis and monitoring cancer progression using NGS and proteomics; b): To investigate the mechanisms of cancer metastasis and chemo-/radio-resistance associated with cancer stem cell (CSC) and tumour microenvironment. 


He is an active member of American Association for Cancer Research (AACR) (USA), Chemistry in Cancer Research (USA), Cancer Metastasis Society (USA), International Cancer Microenvironment Society (USA), He is an adjunct Professor in Zhengzhou University, China since 2018.